发明名称 Tamper resistant dosage forms
摘要 The present invention relates to pharmaceutical dosage forms, for example to a tamper resistant dosage form including an opioid analgesic, and processes of manufacture, uses, and methods of treatment thereof.
申请公布号 US8808741(B2) 申请公布日期 2014.08.19
申请号 US201314040535 申请日期 2013.09.27
申请人 Purdue Pharma L.P. 发明人 McKenna William H.;Mannion Richard O.;O'Donnell Edward P.;Huang Haiyong H.
分类号 A61K9/00;A61K9/20;A61K9/28;A61K47/34;A61K31/485;A61J3/06;A61K47/10;A61K45/06;A61K9/24;A61K9/16 主分类号 A61K9/00
代理机构 Troutman Sanders LLP 代理人 Troutman Sanders LLP
主权项 1. A method of treating pain comprising administering to a patient in need thereof a convection cured shaped tablet comprising an extended release matrix comprising a composition, wherein said tablet comprises: (1) at least one polyethylene oxide having, based on rheological measurements, an approximate molecular weight of 4,000,000, and (2) oxycodone or a pharmaceutically acceptable salt, andwherein said tablet is prepared by a process comprising the steps of: (a) combining at least (1) and (2) to form a blend; (b) shaping said blend to form a shaped tablet; and (c) convection curing said shaped tablet by subjecting the shaped tablet to a temperature from about 60 to about 90° C. for a time of from about 15 minutes to about 10 hours, wherein said wherein said convection cured shaped tablet comprises: (i) 5, 7.5, 10, 15, 20, or 30 mg of said oxycodone or pharmaceutically acceptable salt and at least 79% by weight, based upon the total weight of said composition, of said at least one polyethylene oxide having, based on rheological measurements, an approximate molecular weight of 4,000,000;(ii) 40 mg of said oxycodone or pharmaceutically acceptable salt and at least 72% by weight, based upon the total weight of said composition, of said at least one polyethylene oxide having, based on rheological measurements, an approximate molecular weight of 4,000,000;(iii) 60 mg of said oxycodone or pharmaceutically acceptable salt and at least 57% by weight, based upon the total weight of said composition, of said at least one polyethylene oxide having, based on rheological measurements, an approximate molecular weight of 4,000,000; or(iv) 80 mg of said oxycodone or pharmaceutically acceptable salt and at least 54% by weight, based upon the total weight of said composition, of said at least one polyethylene oxide having, based on rheological measurements, an approximate molecular weight of 4,000,000.
地址 Stamford CT US